Freakonomics Radio
Existing drugs can sometimes be repurposed to treat rare diseases. But making that match can be hard — and the financial incentives are weak. Guest host Steve Levitt tries to solve the puzzle.
- SOURCES:
- Chris Snyder, professor of economics at Dartmouth College.
- David Fajgenbaum, co-founder and president of Every Cure, physician-scientist at the University of Pennsylvania.
- Heather Stone, health science policy analyst at the Food & Drug Administration.
- Sarrin Chethik, senior policy analyst at the Market Shaping Accelerator.
- RESOURCES:
- Chasing My Cure: A Doctor’s Race to Turn Hope into Action; A Memoir, by David Fajgenbaum (2019).
- Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases, by Michael Kremer and Rachel Glennerster (2016).
- Market Shaping Accelerator.
- CURE ID Registry.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

415. How Rahm Emanuel Would Run the World
As a former top adviser to presidents Clinton and Obama, he believes in the power of the federal government. But as former mayor of Chicago, he says that cities are where real problems get solved…
414. Will Covid-19 Spark a Cold War (or Worse) With China?
The U.S. spent the past few decades waiting for China to act like the global citizen it said it wanted to be. The waiting may be over.
413. Who Gets the Ventilator?
Should a nurse or doctor who gets sick treating Covid-19 patients have priority access to a potentially life-saving healthcare device? Americans aren’t used to rationing in medicine, but it’s time to think about it. We…
412. What Happens When Everyone Stays Home to Eat?
Covid-19 has shocked our food-supply system like nothing in modern history. We examine the winners, the losers, the unintended consequences — and just how much toilet paper one household really needs.
411. Is $2 Trillion the Right Medicine for a Sick Economy?
Congress just passed the biggest aid package in modern history. We ask six former White House economic advisors and one U.S. Senator: Will it actually work? What are its best and worst features? Where does…
410. What Does Covid-19 Mean for Cities (and Marriages)?
There are a lot of upsides to urban density — but viral contagion is not one of them. Also: a nationwide lockdown will show if familiarity really breeds contempt. And: how to help your neighbor.
409. The Side Effects of Social Distancing
In just a few weeks, the novel coronavirus has undone a century’s worth of our economic and social habits. What consequences will this have on our future — and is there a silver lining in…
Why Rent Control Doesn’t Work (Ep. 373 Rebroadcast)
As cities become ever-more expensive, politicians and housing advocates keep calling for rent control. Economists think that’s a terrible idea. They say it helps a small (albeit noisy) group of renters, but keeps overall rents…
408. Does Anyone Really Know What Socialism Is?
Trump says it would destroy us. Sanders says it will save us. The majority of millennials would like it to replace capitalism. But what is “it”? We bring in the economists to sort things out…
407. Is There Really a “Loneliness Epidemic”?
That’s what some health officials are saying, but the data aren’t so clear. We look into what’s known (and not known) about the prevalence and effects of loneliness — including the possible upsides.
